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Abstract  Background/Objective:  This  study  sought  to  assess  the psychometric  properties
of the  9-item  Shared  Decision-Making  Questionnaire  (SDM-Q-9)  in patients  with  resected,
non-metastatic  cancer  and  eligible  for  adjuvant  chemotherapy.  Method:  A total  of  568
patients were  recruited  from  a  multi-institutional,  prospective,  transversal  study.  Patients
answered  the  SDM-Q-9  after  visiting  their  medical  oncologist  who,  in turn,  completed  the
SDM-Q--Physician  version.  Reliability,  factorial  structures  [exploratory  factor  analysis  (EFA),  con-
firmatory  factor  analysis  (CFA)],  and convergent  validity  of  the  SDM-Q-9  scores  were  explored.
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Results:  SDM-Q-9  showed  a  clear  factorial  structure,  compatible  with  a  strong  and replicable
general factor  and  a  secondary  group  factor,  in  patients  with  resected,  non-metastatic  cancer.
Total sum  scores  derived  from  the  general  factor  showed  good  reliability  in  terms  of  omega
coefficient: .90.  The  association  between  patient  and  physician  perception  of  SDM was  weak
and failed  to  reach  statistical  significance.  Males  and  patients  over  60  years  of  age  displayed  the
greatest  satisfaction  with  SDM.  Conclusions:  SDM-Q-9  can aid in  evaluating  SDM  from  the  cancer
patients’  perspective.  SDM-Q-9  is helpful  in studies  examining  patient  perspectives  of  SDM and
as an  indicator  of  the  degree  of quality  and  satisfaction  with  health  care  and  patient-physician
relationship.
© 2018  Published  by  Elsevier  Espan˜a,  S.L.U.  on behalf  of  Asociacio´n Espan˜ola  de Psicolog´ıa  Con-
ductual. This  is an open  access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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oncología
Resumen  Antecedentes/Objetivo:  Este estudio  analiza  las  propiedades  psicométricas  del
Questionnaire  Shared  Decision-Making  (SDM-Q-9)  en  pacientes  con  cáncer  resecado,  no
metastásico y  elegible  para  quimioterapia  adyuvante.  Métodos:  Un total  de 568  pacientes
fueron reclutados  en  un  estudio  multi-institucional,  prospectivo,  transversal.  Los  pacientes
respondieron  al  SDM-Q-9  después  de visitar  a  su  oncólogo  que,  a su  vez,  completó  el SDM-Q-
versión médico.  Se  estudiaron  la  fiabilidad,  la  estructura  factorial  (análisis  factorial  exploratorio
y análisis  factorial  confirmatorio)  y  la  validez  convergente  de las  puntuaciones  del  SDM-Q-9.
Resultados: La  escala  SDM-Q-9  mostró  una  estructura  factorial  clara,  compatible  con  un  factor
general fuerte  y  replicable  y  un factor  de grupo  secundario,  en  pacientes  con  cáncer  resecado
y no metastásico.  La  puntuación  del factor  general  mostró  una  buena  fiabilidad  en  términos
de coeficiente  omega:  0,90.  La  asociación  entre  la  percepción  del  médico  y  del paciente  en  la
SDM fue  débil  y  no logró  alcanzar  significación  estadística.  Los  hombres  y  los pacientes  mayores
de 60  an˜os  mostraron  mayor  satisfacción  con  la  toma  de  decisión  compartida.  Conclusiones:
SDM-Q-9  puede  ayudar  en  la  evaluación  de la  toma  de  decisión  compartida  desde  la  perspectiva
de los  pacientes  de  cáncer  y  como  indicador  del grado  de  calidad  y  satisfacción  en  el  cuidado
de la  salud  en  la  relación  médico-paciente.
© 2018  Publicado  por  Elsevier  Espan˜a,  S.L.U.  en  nombre  de Asociacio´n  Espan˜ola  de  Psi-
colog´ıa Conductual.  Este  es  un art´ıculo  Open  Access  bajo  la  licencia  CC BY-NC-ND  (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Recent  years  have  witnessed  growing  interest  in patient
participation  in shared decision-making  (SDM;  Elwyn et al.,
2014),  which  represents  a  shift  in  traditional  forms  of
healthcare,  moving  from  a  paternalistic  model  to  a
more  collaborative  relationship.  In  this  patient-physician
alliance,  the patient’s  (and  family’s)  opinion  implies  the
physician’s  relinquishing  part  of their  control,  contin-
ued  negotiation,  and empowering  the patient  to  develop
their  autonomy  (Coulter  & Collins,  2011;  Schuler et  al.,
2017).  Shared  decision  includes  three  essential  elements:
exchange  of  information  (personal  and medical)  between
patient  and  physician,  deliberation  as to  diagnostic  and
therapeutic  options,  and  reaching  a consensus  (Rodenburg-
Vandenbussche  et al.,  2015;  Shay  & Lafata,  2015).
The  most  common  cause  of patient  dissatisfaction  is  not
being  duly  informed  about  their  medical  condition  and treat-
ment  alternatives  (Libert  et  al.,  2017).  A survey  conducted
in  eight  European  countries  revealed  that  most patients
wanted  to  receive  more  information,  as  well  as  to  partic-
ipate  more  in the decision-making  process,  although  their
expectations  about  their  involvement  in  healthcare  deci-
sions  differed  significantly  across  countries;  for  example,  in
Spain  and  Poland,  patients  preferred  a more  paternalistic
model  than  in Switzerland  or  Germany  (Coulter,  Parsons,  &
Askham,  2008). Likewise,  younger  people  tended  to  prefer
more  patient-based  communications  than  older  people;  this
was  consistent  in all  countries  (Elwyn  et  al.,  2014).
While  great  effort  is  devoted  to  promoting  SDM, it rep-
resents  an important  challenge  for  physicians  (Libert  et al.,
2017)  and  the evidence  regarding  its  impact  continues  to  be
scarce  (Tamirisa  et al.,  2017).  More  reliable  and  valid  tools
are  required  to  assess  SDM’s  effectiveness  and  shed greater
light  on  its  phases  and  correlates.  The  nine-item  Shared
Decision  Making  Questionnaire  (SDM-Q-9)  is  a  questionnaire
designed  to  probe  the SDM  process  (Kriston  et  al.,  2010).
The  original  version  was  developed  in Germany  and  based  on
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Elwyn’s  competences  model  for  patient  participation  and on
additional  psychological  theories  (Kriston  et  al.,  2010;  Simon
et  al.,  2006).  This  24-item  version  was  reviewed  and  reduced
to  a  9-item  scale,  the  SDM-Q-9,  which  displays  excellent
internal  consistency,  high  inter-item  discrimination  and  fac-
torial  validity  (Kriston  et  al.,  2010;  Scholl,  Kriston,  Dirmaier,
&  Härter,  2015). The  SDM-Q-9  has  become  a  commonly  used
tool  for  measuring  SDM  in clinical  practice  and has been
translated  into several  languages,  including  English (Kriston
et  al.,  2010;  Scholl,  Kriston,  Dirmaier,  Buchholz,  &  Härter,
2012)  and  Spanish  (De  las  Cuevas  et al.,  2015).  To  date,  it
has  not  been  applied  or  validated  in  cancer  patients.
Cancer  is a leading  public  health  problem,  given  its
incidence  and  mortality  worldwide  (Jönsson,  Hofmarcher,
Lindgren,  &  Wilking,  2016).  In  non-metastatic  cancer,
surgery  and  adjuvant  chemotherapy  can be  curative  and
temporarily  impact  quality-of-life,  due  to  treatment-related
adverse  effects  or  sequelae  (Jönsson et al.,  2016). Nev-
ertheless,  in  this  context  of  uncertainty  about  prognosis
and  emotional  stress,  patient-based  communication  and
SDM  regarding  adjuvant  therapy  should  not only increase
patients’  degree  of  satisfaction,  but  also  their  resilience,
adherence  and  tolerance  to  chemotherapy,  and the  clinical
course  of  their  disease,  in addition  to  mitigating  repercus-
sions  on  their  quality-of-life  (Libert  et  al.,  2017). Likewise,
individualized  treatments  have  proven  to  benefit  cancer
patients’  quality-of-life  (De  Torre-Luque,  Gambara,  López,
&  Cruzado,  2016).
The present  instrumental  study  (Carretero-Dios  & Pérez,
2005;  Ramos-Álvarez,  Moreno-Fernández,  Valdés-Conroy,
&  Catena,  2008)  attempted  to  assess  the  psychometric
properties  of  Shared  Decision  Making  Questionnaire-version
patient  (SDM-Q-9;  Kriston  et  al.,  2010)  in  Spanish  patients
with  resected,  non-metastatic  cancer  who  were  eligible  to
receive  adjuvant  chemotherapy.  The  properties  assessed
were:  factorial  structure,  reliability  of  the derived  scores,
and  construct  validity.
Method
Participants
The  sample  consisted  of  568 cancer  patients;  59.8%  (n=338)
were  women  and  the  average  age  was  59.1  years  (SD=12.1,
range  26-84).  Most  patients  were  married  or  lived with
a  partner  (77.1%)  and  had completed  primary  education
(58.3%).  The  most common  employment  status  was  retired
(60.0%).  The  sample’s  clinical  characteristics  revealed  that
the  most  common  types  of  cancer  were  colon  (40.5%,
n=230),  and  breast  (33.5%, n=190).  All  relevant  socio-
demographic  and  medical  characteristics  are included  in
Table  1.
Patients  were  recruited  by  30  medical  oncologists  from
14  Spanish  hospitals;  78.1%  (n=25) of  these  specialists
were  female;  mean  age  was  35  years  (SD=7.4,  range  27-
62  years),  and 11.9  years  of  experience  in caring  for
cancer  patients  (SD=8.8,  range  3-37  years).  Most  were  super-
specialists  (68.8%)  working  at  a public,  teaching  hospital
(53.1%).
Table  1  Patient  and  physician  characteristics.
Patient  and  physician  characteristics  n  %
Patient  characteristics  (n=568)
Age (mean;  standard  deviation) 59.1  12.1
Gender
Male  230 40.5
Female  338 59.5
Marital  Status
Married/partnered  438 77.1
Single  49  8.6
Widowed  48  8.5
Divorced/separated  33  5.8
Educational  level
Primary  331 58.3
High School  153 26.9
University  84  14.8
Employed
No 330 60.0
Tumor  site
Colon  230 40.5
Breast  190 33.5
Stomach  36  6.3
Others  112 19.7
Stage
I 128 22.5
II 193 34.0
III 232 40.8
Unknown  15  2.6
Time  since  diagnosis  (days,  mean;  SD)  90.9  (126.1)
Physician  characteristics  (n=30)
Gender: Female  25  78.1
Medical  oncologist:  specialized  22  68.8
Type  of hospital: teaching  17  (53.1)
Age  (years,  mean;  SD) 35.0  (7.4)
Number  of  years  employed  (mean;  SD)  11.9  (8.8)
Note. n: number, SD:  standard deviation, %: percentage.
Instruments
SDM-Q-9  is  a brief,  valid,  and  reliable  questionnaire  that
evaluates  the SDM  process  from  the patient’s  perspective
(Kriston  et  al.,  2010), adapted  to  Spanish  (De las  Cuevas
et  al.,  2015). The  questionnaire  contains  nine  items,  each
describing  one  step of  the SDM  process  (Simon et  al.,  2006),
it  was  developed  to  assess  the degree  to  which  patients
feel  involved  in the decision-making  process.  The  items
are  scored  from  0 to 5  on  a six-point  Likert  scale  ranging
from ′′completely  disagree′′ (0) to ′′completely  agree′′ (5).
Standard  scoring  is  a simple  sum  score  with  values  between
0  and  45.  Internal-consistency  (alpha)  reliability  estimates
are  generally  high  in  patients  with  chronic  diseases:  .98
(Germany),  .94  (U.S.),  and  .88 (Spain).
SDM  Questionnaire-Physician’s  version  (SDM-Q-Doc)  is  a
questionnaire  that  evaluates  the  physician’s  perspective
and  how  well  they  follow  SDM  with  their  patients  (Scholl
et  al.,  2012).  It  was  adapted  and  validated  to  Spanish
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(Calderon  et al.,  2017). The  questionnaire  consists  of  nine
items,  each  of  which  describes  one  step of  the  process.  The
items  are  scored  from  0 to  5  on  a six-point  Likert  scale  as
‘‘completely  disagree’’  (0)  to  ‘‘completely  agree’’  (5). A
simple  sum-score  with  possible  values  between  0  and  45  is
obtained.  In this  study,  Cronbach’s  alpha  for the  scale  was
.90.
SIS  is  a  4-item  scale  that  was  created  to  ascer-
tain  patients’  degree  of  satisfaction  with  the  information
provided  by  their  physician about  the disease,  risk  of recur-
rence,  side  effects  of  treatment,  and time  dedicated  to
informing  them.  The  scale  provides  two  subscales:  satis-
faction  with  the  information  provided  and  satisfaction  with
the  time  dedicated.  Items  are scored  from  0 to  4 on  a five-
point  Likert  scale  ranging  from ′′completely  disagree′′ (0)  to
′′completely  agree′′ (4); the higher  the score, the greater
the  satisfaction  with  the information  provided.  The  scale
revealed  a Cronbach’s  alpha  value of  .82  in our study.
The  patients’  medical  and  demographic  variables
included  were:  age,  gender,  marital  status,  educational
level,  occupational  sector,  tumor  site,  stage,  and  time  since
diagnosis.  The  oncologist-related  variables  included  age,
gender,  years  of  experience,  area  of  specialization  (general
(treating  all kinds  of  tumors)  vs.  super-specialized  (treating
one  specific  subtype  of  tumor)  and  type  of  hospital  (aca-
demic  vs. non-academic).
Procedure
This  is  a  multi-institutional,  prospective,  transversal,  obser-
vational  study  that  pooled  consecutive  patients  recruited
at  14  Spanish  teaching  hospitals  from  June  2015  to  May
2017.  The  study  is  part  of  a research  program  investigating
patients  with  cancer;  it is  funded  by  the  Continuous  Care
Group  of  the  Spanish  Society  of  Medical  Oncology  (SEOM).
The  study  was  approved  by  the Ethics  Review  Board  at each
institution  and  by  the  Spanish  Agency  of Medicines  and  Medi-
cal  Devices  (AEMPS).  Inclusion  criteria  were  being ≥18 years
of  age,  having  a histologically  confirmed,  non-advanced,
solid  tumor  surgically  treated  for which  international  clini-
cal  guidelines  consider  adjuvant  treatment  to  be  an option.
Patients  with  metastatic  disease,  treated  with  preopera-
tive  radio-  or  chemotherapy,  or  with  adjuvant  hormonal  or
radiotherapy  without  chemotherapy  were  excluded.  Simi-
larly,  physical  ailments,  comorbidity,  and/or  age  precluding
chemotherapy,  and personal,  psychological,  family,  socio-
logical,  geographical,  and/or  underlying  medical  condition
that,  in  the  investigator’s  opinion,  could  hinder  the  indi-
vidual’s  ability  to participate  in the  study  were  also  cause
for  exclusion,  since  these  patients  did not have to  decide
on  adjuvant  therapy.  The  evaluation  was  performed  in all
cases  approximately  one month  following  surgical  resection,
in  the  context  of  patients’  first  visit  with  the oncologist
to  decide  on  adjuvant  chemotherapy.  Data  collection  pro-
cedures  were  similar  at all  hospitals.  Participation  was
voluntary,  anonymous,  and  would not  affect  their  care  in
the  slightest.  The  participants  completed  the questionnaires
individually,  with  no limit  on  time.  Data  were  collected  and
updated  by  medical  oncologists,  specifically  trained  to  com-
ply  with  the study  requirements,  via a web-based  platform
(www.neocoping.es).  Of  the  627  patients  screened,  59  were
not  eligible  (17  did not  meet  inclusion  criteria;  23 met  exclu-
sion  criteria  and  19  had  incomplete  data).
Data  analysis
Descriptive  analyses  were conducted  for every  SMD-Q-9  item
and  explored  means  standard  deviations  and  distributions
of  the item  scores.  To  assess  the factorial  structure  of  the
scale,  the  sample  was  randomly  split  into  two  groups  and
different  Exploratory  Factor  Analysis  (EFA)  solutions  based
on  previous  reported  results  were  performed  on  the  first
split-half  sample.  The  adequacy  of  the inter-item  correla-
tion  matrix  to  be factor  analyzed  was  first  assessed  using
the Kaiser-Meyer-Olkin  (KMO)  measure  of  sampling  ade-
quacy.  The  different  hypothesized  solutions  were  next  fitted
by  using  robust,  unweighted  least squares  estimation  with
mean-and-variance  corrected  fit statistics  as  implemented
in the  FACTOR  program  (Lorenzo-Seva  & Ferrando,  2013).
They  were:  (a)  unidimensional  (as  the scale  was  initially
designed  to  be single-trait),  (b)  unidimensional  with  item
1  omitted  (De  las  Cuevas  et  al.,  2015) and  (c)  bidimensional
with  correlated  factors.  From  the  EFA  results,  a simple  and
clearly  interpretable  bifactor  structure  (Lorenzo-Seva  & Fer-
rando,  2013)  could  be specified.  This  structure  was  next
fitted  to the  entire sample  with  FACTOR  by  using  the  same
estimation  procedure  described  above.
In  all the  tested  solutions  above,  the  goodness-of-fit
indices  used to  assess  model-data  fit  were:  (a)  RMSEA,  with
its  95%  confidence  interval  (as  a measure  of  approximate
fit);  (b)  Goodness-of  fit-index  (GFI),  and (c)  the root  mean
square  of  the standardized  residuals  (z-RMSR),  (as absolute
measures  of  fit),  and  (d)  the  comparative  fit index  (CFI),
(as  a relative  measure  of  fit with  respect  to  the null  inde-
pendence  model).  We  followed  the  usual  rules  in deciding
model  appropriateness  (Schermelleh-Engel,  Moosbrugger,  &
Müller,  2003).  In  addition  to  model-data  fit  measures,  addi-
tional  indices  of  appropriateness  for  assessing  the  strength
and  replicability  of the  solution  (H  index)  as  well  as  close-
ness  to unidimensionality  (ECV  index)  were also  obtained
(Ferrando  & Lorenzo-Seva,  2017).
Once  the proposed  structure  had  been  fitted  and found
appropriate,  scores  based  on  this  structure  were  obtained
and  their  reliability  was  assessed  by  using  the  omega  coef-
ficient  (McDonald,  1999). Finally,  construct  and external
validity  were  assessed  on  the  basis  of  these  scores  by  using
product-moment  correlations  and  univariate  ANOVA-based
mean-group  comparisons  using  Bonferroni  corrections.  For
all  the tests  conducted,  bilateral  statistical  significance  was
set  at p≤.05.
Results
SMD-Q-9  item  descriptive  and  factor  analysis
Item  means  ranged  from  2.59  (item  8)  to  3.81  (item  1)
and  the  mean  sum  of  SDM-Q-9  was  3.15  (SD=0.9).  In  gen-
eral,  the item  scores  were  negatively  skewed  and  with
high  kurtosis  values.  So,  we  decided to  use  the underlying-
variables  approach,  and  fit  the  FA models  to  the  inter-item
polychoric  correlation  matrix  (more  details  in  (Ferrando  &
Lorenzo-Seva,  2013).  This  approach  is quite  feasible  here
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Table  2  Descriptive  and  factor  analysis  results  (bifactor  solution)  of  Shared  Decision-Making  Questionnaire  (SDM-Q-9).
Questions  M  SD General  Factor  Group  Factor
1  My  doctor  made  it  clear  that  a  decision  must  be  made.  3.81  0.6 .27  .87
2 My  doctor  wanted  to  know  exactly  how  I want  to  be
involved  in making  the  decision.
3.50  0.9 .51  .54
3 My  doctor  told  me  that  there  are different  options  for
treating my  condition.
3.22  1.2 .62  .49
4 My  doctor  precisely  explained  the  advantages  and
disadvantages  of  the  treatment  options.
3.39  1.1 .56  .62
5 My  doctor  helped  me  understand  all the information.  3.69  0.7 .37  .79
6 My  doctor  asked  me  which  treatment  option  I prefer.  2.62  1.5 .91
7 My  doctor  and  I weighed  the  different  treatment  options
thoroughly.
2.62  1.5 .98
8 My  doctor  and  I selected  a  treatment  option  together.  2.59  1.5 .98
9 My  doctor  and  I came  to  an agreement  on how  to  proceed.  3.02  1.4 .79
Note. M: mean, SD: standard deviation. Score ranges from 0 (strongly disagree) to 5 (strongly agree). Loadings lower than absolute .25
were omitted.
given  that  the  test  is  short  and  the sample  reasonably  large.
Finally,  regarding  model  adequacy,  the  KMO  index  (.87)  sug-
gested  that  the  inter-item  correlations  were  substantial  and
appropriate  for  being  factor  analyzed.  Table  2 presents  the
descriptive  statistics  corresponding  to  the SDM-Q-9  items.
Because  a clear  final  structure  was  attained  in the  entire
sample,  only a summary  of  the  previous  exploratory  results
will  be  provided  here.  The  unidimensional  model  with  the
original  9  items  was  untenable  by  all  the standards.  Omitting
item  1 considerably  improved  the fit bringing  it to  the lower
limits  of  acceptability  and  providing  an ECV  estimate  of  .80,
which  means  that 80% of  the common  variance  of  the item
scores  can  be  explained  by  a  general  factor.
The  solution  in two  factors  had  an  excellent  fit  and  was
interpretable:  factor  1 clustered  the items  1,  2,  3, 4, and
5  that  assess  the  information  and explanations  provided  to
the  patient  by  the  physician  about  treatment  and  the advan-
tages and  disadvantages  of  the different  options. Factor  2
clustered  the  items  6, 7, 8, and  9 that  appraise  the choice  of
the  best  treatment  option  for  the  patient.  However,  items
1  and  9 were  factorially  complex,  with  substantial  loadings
on  both  factors.  Factor  1  was  stronger  and  better  defined,
with  a  replicability  H index  of  .82  (Ferrando  & Lorenzo-Seva,
2017)  whereas  that  of  factor  2  was  only .75.  Finally,  the
estimated  inter-factor  correlation  was  rather  high:  r=.61.
To  sum  up,  the initial analyses  suggest  that  a  unidi-
mensional  solution  omitting  item  1 is  almost  acceptable,
whereas  the  bidimensional  solution  fits  very  well  and  has
a  clear  interpretation,  although  it  consists  of  two  short
and  highly  correlated  factors,  one  of which  is  relatively
weak,  with  low replicability.  Consequently,  no  highly  reli-
able  scores  can  be  expected  to  be  derived  from  this factor.
In  view  of these  results  we  considered  that  the  most  appro-
priate  and  parsimonious  solution  for the  SDM-Q-9  items  was  a
bifactor  solution  (Rodriguez,  Reise,  &  Haviland,  2016)  based
on  all  9  items,  with  a  general  factor  that  describes  the entire
SDM  process,  and  a group  factor  defined  by  items  1  to  5
related  to  the  information  and  treatment  options  provided
to  the  patient.  The  bifactor  solution  is  justifiable,  given
the  data’s  essential  unidimensionality;  it also  maintains  the
parsimony  and  strength  advantages  of the  unidimensional
solution  (clear  interpretation  and  high  reliability  of  the gen-
eral  factor).  At  the same  time,  the additional  inter-item
covariance  between  items  1  to 5  that  cannot  be  explained
by  the general  factor  is  modeled as  a  group  factor,  thereby
avoiding  potential  bias  on the general  factor  due to  unmod-
eled  inter-item  covariance.
Factor  analysis  solution
On  the basis  of  the  EFA results  summarized  above,  a  bifactor
SCFA  solution  was  fitted  to  the  entire  sample  data  with  the
following  specifications:  factor  1  (the  general  factor)  was
defined  by  all  9  items,  and  factor  2  (the  group  factor)  was
defined  by items 1  to  5. As  in  the  previous  EFAs, the  bifactor
model  was  fitted  by  using  robust  ULS  estimation  as  imple-
mented  in FACTOR.  Goodness-of-fit  results  are  in Table 3  and
indicate  an excellent  fit.
The  general  factor  in  Table  3 is well  defined  by  the  9  items
with  all loadings  >.30  except  for  item  1  (as expected  from
previous  results).  These  loadings  can  be  interpreted  as  item
discriminations  and  are reasonably  acceptable  for a  person-
ality  measure.  The  H-index  is  therefore  rather  high:  0.88,
meaning  that  the factor  is  strong,  well  defined,  and  likely  to
replicate  across  different  samples.  The  second  group  factor
is  mainly  defined  by  items  1 and  5, which  have  high  loadings
on  it and  only  moderate  loadings  on  the  general.  In  this case,
the  H-index  is only  0.73,  which  means  that  the group  fac-
tor  is  far  weaker  than  the  general  factor,  the  most  common
result  in bifactor  solutions  (Rodriguez  et  al.,  2016).
To  assess  the  invariance  of  the solution  described  thus  far,
a series  of analyses  were  performed  by  splitting  the entire
sample  into  subsamples  according  to  gender  and  pathology
type.  In all  cases,  the results  were  found  to  be essentially
invariant,  both  in terms  of item  locations  and  item  dis-
criminations.  Thus,  there  appears  to  be no  differential  item
functioning  for  any  of  the items  and the scale  is  expected  to
function  with  the  same  properties  in the general  population
for  which  it is  intended.  Given  the  space  limitations,  the
invariance  results  are not provided  here,  but  are available
from  the  authors.
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Table  3  Robust  goodness  of  fit  statistics.
Descriptive  fit  indices  BC  Boostrap  95%  confidence  interval
Lower  Upper
Root  Mean  Square  Error  of  Approximation  (RMSEA)  .03  .00  .05
Root Mean  Square  of  Residuals  (RMSR)  .03  .02  .050
Comparative Fit  Index  (CFI)  .99  .99  1.00
Goodness of  Fit  Index  (GFI)  .99  .99  1.00
Note. Cut off criteria: RMSEA ≤.06, CFI and GFI >.95 and RMSR ≤.08.
Scoring  and reliability
The  clear  bifactor  solution  discussed  above  allows  two
summed  scores  to  be  obtained.  First  is  the  sum  of  the  scores
for  all  9 items, which  represents  the  general  factor,  and
so,  aims  to  measure  a general  dimension  of  perspectives
regarding  the  decision-making  processes.  The  second  score
is  the  sum  of  items  1  to  5, represents  the group  factor  above,
and  measures  a more  specific  sub-dimension  of  information
and  treatment  options  provided  to  the patient.  From  the H
results  above  and  also  from  basic  psychometric  principles,
the  total  sum score  is expected  to  be  more  reliable  than  the
group  sum  score, and this  was  indeed  the case.  The  omega
reliability  estimates  were  .90  for  the  total  scores  and  .85  for
the  group  scores.  So,  both  scores  achieve  a quite  acceptable
degree  of  accuracy,  and the total  scores  in particular  would
be  considered  as  accurate  enough  for  clinical  (individual)
assessment.  Overall,  the total  scores  are  more  representa-
tive  of  the entire  SDM process  and  will  be  the ones  used  in
the  validity  assessments  below.
To  ascertain  whether  the reliability  of the total  scores
reflects  accuracy  at all  trait levels, conditional  reliabilities
were  also estimated  (see  Ferrando  &  Lorenzo-Seva,  2017).
Results  revealed  that conditional  reliabilities  were  >.85  for
a  range  of trait values  between  two  standard  deviations
below  the  mean  and two  standard  deviations  above  the
mean.  Hence,  not only do the  SDM  scores  possess  good  over-
all  reliability,  but  this reliability  is  also  high  for  almost  the
entire  effective  trait  range,  and  the  .90  estimate  reported
above  is  thus  representative  of  the overall  precision  of  these
scores.  This  result  is  a positive  feature  of  the  instrument
and  suggests  that  SDM  would enable  most  respondents  to  be
accurately  assessed.
Finally,  given  the results  summarized  in this section,  and
for  the  benefit  of  practitioners,  a normative  table  based  on
the  total  sum  score  was  constructed  based on the  entire
sample  data.  The  table  is  provided  as  supplementary  mate-
rial.
Construct  validity
Construct  validity  was  explored  by  analyzing  the  product-
moment  correlations  between  the total  SMD-Q-9  scores
(as  proxies  for  the general  SDM  dimension)  and  scores
from  other  questionnaires  aimed  at measuring  theoretically-
linked  dimensions.  Results  indicated  that  the total  SMD-Q-9
score  relates  positively  with  satisfaction  regarding  the
patient-physician  relationship  (r=.29,  p<.001),  specifically
with the time  dedicated  (r=.40,  p<.001),  but  not with
the  information  provided  (r= -.02,  p=.313).  Similar  results
were  found  with  the  group factor  SDM-Q-9,  which  related
positively  with  satisfaction  regarding  the patient-physician
relationship  (r=.36,  p<.001)  and  time  dedicated  (r=.32,
p<.001),  but  not with  information  provided  (r=.07,  p=.313).
Significant  correlations  were found  between  SDM-Q-9,
patient  version,  and  SDM-Q-Doc,  physician  version  (r=.14,
p<.001),  between  women  (r=.21,  p<.001),  but  not in men  (r=
-.04,  p=.464)  and  estimated  risk  of  relapse  (r=.04,  p=.289).
Gender,  age  and  SDM-Q-9
Men  tended  to  exhibit  greater  satisfaction  with  the  SDM
than  women  (F(1,566) =10.96,  p<.001)  and patients  over  60
years  (n=288)  more  than  younger  ones  (n=270)  (F(1,556) =5.19,
p=.023)  with  significant  intergroup  differences  (F(3,552)=7.53,
p<.001).  Furthermore,  the subsequent  post-hoc  Bonferroni
analysis  uncovered  significant  gender-  and  age-based  differ-
ences  (p<.005)  such  that  women  under  the age  of 60  years
were  the least  satisfied  group  with  SDM  versus  men  of  the
same  age,  or  older  women  (see  Figure  1).
Discussion
The  aim  of the present  study  was  to  analyze  the psychomet-
ric  properties  of  SMD-Q-9  created  by  Kriston  et  al. (2010)  in
a  population  of patients  with  resected,  non-metastatic  can-
cer  and  in  the  context  of  potentially  curable  disease.  To  the
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Figure  1  Mean  9-item  Shared  Decision-Making  Questionnaire
(SDM-Q-9)  scores  by  gender  and  age.
Note. Horizontally,  the  figure  shows  patients  grouped  by  gender
(man  or  woman)  and  by  age  (≥  or  <60 years)  and  vertically,  the
score on  the Shared  Decision-Making  Questionnaire  (SDM-Q-9).
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best  of  our  knowledge,  this is  the  first  report  of  the SMD-Q-
9’s  psychometric  properties  in  oncology,  and,  in this type of
population,  it showed  several  positive  properties.  First  the
obtained  factorial  structure  was  clear  and  meaningful,  with
a  strong  and  replicable  general  factor  and  a more  specific
group  factor  that can  be  of  interest  in finer  graded  clinical
assessment.  The  present  results  are compatible  with  pre-
vious  results  reported  by  Kriston  et al. (2010)  and  De las
Cuevas  et al.  (2015),  in  that the  scale  was  considered  as
essentially  unidimensional.  In line  with  these previous  stud-
ies,  we  also  find  item  1  (′′My  doctor  made  it clear  that  a
decision  must  be  made′′) to  be  the most  problematic,  with
low  discriminating  power  and  high  specificity.  Second,  sum-
scores  derived  from  the factor  solution,  especially  those
corresponding  to the general  factor  were  quite  accurate,
with  an  omega  estimate  .90, in  line  with  previous  reported
reliabilities.
Validity  results  were  less  strong.  Convergent  validity  was
explored  by  comparing  it  to  the SDM-Q-Doc  and  Satisfac-
tion  with  the  Information  (SIS).  Only  a weak  and  statistically
significant  correlation  was  found  between  SDM-Q  patient
version  and  physician  version.  Correlations  between  SDM-
Q-9  and  SIS  were  positive  and significant,  but  only insofar as
the  time  dedicated  to  informing  was  concerned,  but  not  with
the  information  provided.  Thus,  the hypothesis  of  a substan-
tial  correlation  between  the availability  of  two  instruments
-- the  SDM-Q-9  (Kriston  et  al.,  2010)  and  SDM-Q-Doc  (Scholl
et  al.,  2012), comparing  the patient’s  and  physician’s  per-
spectives  on the SDM  process  --  has  been  slightly  established.
Patients  seem  to  expect  more  information  from  their  doc-
tors.
Overall,  the psychometric  results  of our study  were  con-
sistent  with  the results  from the original  German  scales,  as
well  as the  Dutch  and  Spanish  versions.  Differences  might
be  explained  by  factors  such  as  the  scale’s  ceiling  effect,
patients’  age and  gender,  and type  of  care. As  mentioned
above,  item  scores  were negatively  skewed,  which  means
that  the  full  scale  has  a  ceiling  effect.  The  use  of the FA
based  on polychoric  correlations  was  expected  to  correct
for  this  problem  as  far  as  assessment  of factorial  structure
was  concerned.  However,  the reduced  variance  due  to  the
end  effect  can  be  expected  to  attenuate  both  the  reliabil-
ity  and  the  validity  estimates  based  on  the sum  scores.  The
ceiling  effect  might  be  caused  by  social  desirability  (Mead  &
Bower,  2000) and  the patient’s  wish  to  please  the physician
that  typically  occurs  when  measuring  patient  satisfaction
(Chewning  et  al.,  2012). Similar  results  were  found  by  Scholl
et  al.  (2015)  who  found  weak  correlations  between  SDM-
Q-9  and  OPTION  scales.  Both  instruments  assess  behavioral
aspects  of  the  decision-making  process.  Moreover,  it should
be  also  noted  that  in  our  study,  the  questionnaires  were  pro-
vided  after  the  initial  visit to  the oncologist  and  completed
immediately  afterward.  This  could  increase  the social  desir-
ability  bias  and  must  be  taken  into  account  for  recruitment
in  future  research.
Our  sample  consisted  of  relatively  older  patients  (mean
age  of  59  years)  compared  to  the  samples  in  the Spanish
validation  study  (mean  age,  45  years).  Older  people are
often  more  satisfied  with  the information  provided  by  the
physician  and  have  less  expectations  surrounding  their  par-
ticipation  in  SDM  (Singh,  Butow,  Charles,  &  Tattersall,  2010).
Our  sample  also  presents  a marginally  higher  percentage
of  women  (59.5%),  similar  to  the Dutch  sample  (60%)  and
slightly  lower  than  the  Spanish  validation  one  (70%).  Previ-
ous studies  have  found  that  female  cancer  patients  are  more
likely  to  prefer  SDM  than  males  (Olson  & Windish,  2010; Singh
et  al.,  2010), and demand  to  participate  in the process  more
than  their  counterparts.
Some  studies  suggest  that  response  patterns  may  differ
depending  on  age,  gender,  and  medical  condition  (O’Connor
et  al.,  2009).  The  fact  that  our  sample  consisted  solely  of
oncological  patients  may  have  contributed  significantly  to
the  differences  detected.  The  growing  complexity  of  adju-
vant  therapies  used  in the treatment  of  cancer  complicates
SDM  as  it pertains  to  the best treatment  and  adds  prognos-
tic  uncertainty  and  fear  to  the negative  consequences  of
inappropriate  decisions  (Thorne,  Oliffe,  & Stajduhar,  2016).
Future  research  concerning  the  construct  validation  and  pre-
dictive  validity  of  the scale  are needed,  including  different
subtypes  of  cancer  and  at  different  stages.
Finally,  the SDM-Q-9  may  not  capture  aspects  of  the visit,
such  as  communication  style,  body  language,  or  empathy,  all
of  which  correlate  highly  with  satisfaction.
This  study  presents  certain  limitations  that  must  be taken
into  account  for  future  research.  First  of  all, although  our
sample  size  is  large,  participants  were  patients  with  a  local-
ized  tumor  who  had  undergone  surgery  and were  candidates
for  adjuvant  chemotherapy.  In  the  future,  we  would  advise
expanding  the sample  to  include  other  tumor  stages  and
types  with  the aim  of confirming  these results,  as  well  as
to compare  different  clinical-pathological  and  social  varia-
bles. Secondly,  the  SDM-Q-9  self-report  subjective  measures
may  not  accurately  reflect  patients’  experiences,  expecta-
tions,  and behavior,  having  limitations  such  as  response  bias
(social  desirability,  inaccurate  memory,  etc.)  and  their  diffi-
culty  in  fully  comprehending  the  SDM  process  (Shay  &  Lafata,
2015). Finally,  in addition  to  this  design,  it  would  be  fit-
ting  to  explore  the dynamic  nature  of  SDM  processes  with
other  longitudinal  studies  that  enable  SDM  to  be evaluated
more  comprehensively,  exploring  its effects  before  and  after
a  decision  is  made.
In  conclusion,  the  ‘‘Shared  Decision  Making  Question-
naire’’  applied  to  patients  with  cancer  possesses  adequate
psychometric  properties,  similar  to  those  obtained  by
Kriston  et al.  (2010),  Simon  et  al. (2006),  and  De  las  Cuevas
et  al. (2015).  The  results  of  this study prove  that  it is  a
valid  and reliable  tool  for  analyzing  and attaining  greater
insight  into  the SDM  process.  On the  other  hand,  knowing
which  conditions  help  or  hinder  engagement  in this  decision-
making  process  can  help  to  establish  the clinical  conditions
necessary  to enhance  patients’  wellbeing.
SDM  is  a process  aimed  at learning  patients’  preferences
and  needs  and toward  empowering  them to  take  an  active
role  in caring  for their  health  in line  with  their  wishes. The
SDM-Q-9  can  be useful  to  analyze  these patients’  perspective
of  the  SDM  and as  an indicator  of  quality  and satisfaction
with  healthcare  services.
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